Thousand Oaks Search Engine


4thousandoaks.com is a topic specific search engine. For general search and other targeted search topics, please use 4Search.com


thumbnail favicon yahoo.com —  2+ day ago

Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

yahoo.com > now

...years, with 25 percent vesting on the first quarterly vesting date after the first anniversary of the vesting commencement date and the remainder vesting in 12 approximately equal quarterly installments over the following three years, subject to the employee being continuously employed by Atara... ...Atara is headquartered in Southern California. For additional information...

thumbnail favicon news.yahoo.com —  1+ day ago

Lopez comes off bench to put Oxnard College men's soccer team into state final

news.yahoo.com

...Substitute Alfonso Lopez curled in a left-footed shot from the right with 12 minutes to play to lift Oxnard College to a 1-0 win over Merced College on Friday afternoon in the CCCAA state semifinals at American River College in Sacramento.... ...San Antonio College for the state championship Sunday afternoon in Sacramento. "It's great to be in the final," Greaney said. Oxnard will get midfielder Noe Eulloqui (Thousand Oaks) back for the final....

thumbnail favicon markets.businessinsider.com —  3+ day ago

AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022

markets.businessinsider.com > news > stocks

...THOUSAND OAKS, Calif., Dec. 1, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new Phase 1 data from AMG 133, a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule.... ..."AMG 133 was designed based on preclinical and human genetic data that strongly suggest GIPR inhibition as a strategy for weight loss, especially in combination with GLP-1 agonism," said David M. Reese, M.D., executive vice president of Research and Development at Amgen....



**Content contained on this site is provided on an “as is” basis. 4Internet, LLC makes no commitments regarding the content and does not review it, so don't assume that it's been reviewed. What you see here may not be accurate and should not be relied upon. The content does not necessarily represent the views and opinions of 4Internet, LLC. You use this service and everything you see here at your own risk. Content displayed may be subject to copyright. Content is removed on a case by case basis. To request that content be removed, contact us using the following form: Contact Us.